A pilot study on faecal MMP-9: a new noninvasive diagnostic marker of colorectal cancer
Open Access
- 23 February 2016
- journal article
- research article
- Published by Springer Nature in British Journal of Cancer
- Vol. 114 (7) , 787-792
Abstract
Colorectal cancer (CRC) is one of the leading malignancies worldwide, therefore cheap noninvasive screening methods are of great importance. Matrix-metalloproteinase-9 (MMP-9) has a role in the progression of CRC, and its level is elevated in tumour biopsies. Faecal MMP-9 levels are increased in active ulcerative colitis patients, but in CRC patients, they have never been measured. We aimed to assess the faecal MMP-9 levels in patients undergoing total colonoscopy according to endoscopic and histological diagnosis. One hundred and nine patients provided faecal samples for MMP-9 analysis. A total colonoscopy was performed; suspicious lesions were evaluated by histology. Faecal MMP-9 levels were measured by ELISA. The number of patients allocated to different groups were: negative/diverticulosis: 34 (referred to as controls); hyperplastic polyps: 15; adenomas: 32 (22 at high risk); and CRC: 28. Faecal MMP-9 was significantly increased in CRC compared with all other groups (P<0.001). Faecal MMP-9 was suitable to distinguish CRC patients from controls (sensitivity: 89.3%; specificity: 91.2%). By means of a lower cutoff level, faecal MMP-9 identified high-risk adenomas besides CRC (sensitivity: 76%; specificity: 85.3%). This lower cutoff level screened 59% of high-risk adenomas. Faecal MMP-9 may be a promising new noninvasive marker in CRC.Keywords
This publication has 36 references indexed in Scilit:
- Fecal Molecular Markers for Colorectal Cancer ScreeningGastroenterology Research and Practice, 2011
- The diagnostic value of matrix metalloproteinase 9 (MMP-9) and tissue inhibitor of matrix metalloproteinases 1 (TIMP-1) determination in the sera of colorectal adenoma and cancer patientsInternational Journal of Colorectal Disease, 2010
- Circulating levels of matrix metalloproteinase-9 (MMP-9), neutrophil gelatinase-associated lipocalin (NGAL) and their complex MMP-9/NGAL in breast cancer diseaseBMC Cancer, 2009
- Stool Methylation-Specific Polymerase Chain Reaction Assay for the Detection of Colorectal Neoplasia in Korean PatientsDiseases of the Colon & Rectum, 2009
- Asia Pacific consensus recommendations for colorectal cancer screeningGut, 2008
- Sensitivity and specificity of faecal tumour M2 pyruvate kinase for detection of colorectal adenomas in a large screening studyBritish Journal of Cancer, 2008
- Urinary Biomarkers Predict Brain Tumor Presence and Response to TherapyClinical Cancer Research, 2008
- Peirce, Youden, and Receiver Operating Characteristic CurvesThe American Statistician, 2007
- Elevated serum matrix metalloproteinase 9 (MMP-9) concentration predicts the presence of colorectal neoplasia in symptomatic patientsBritish Journal of Cancer, 2007
- The evolution to stool DNA testing for colorectal cancerAlimentary Pharmacology & Therapeutics, 2004